Salesforce has been in talks to acquire Listen Labs, an artificial intelligence-powered customer research platform, for about $2 billion, Business Insider reported Wednesday (Sept. 9), citing unnamed sources.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Salesforce bulls are pointing to an AI monetization curve that is bending sharply upward, but the bears have real ammunition too, and with Dreamforce and Investor Day arriving next week, the stock sits at a crossroads where the next few
CRM's 34% monthly rally is backed by stabilizing growth, surging Agentforce ARR and a valuation below major enterprise software rivals.
Salesforce just posted an earnings beat that sent the stock surging 34%, but the source of that surprise raises questions every investor should answer before buying in at these levels.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
I am initiating coverage of Salesforce with a Buy rating with a $430 price target, as AI is proving to be a monetization layer rather than a threat. My investment thesis is driven by Agentforce monetization, Data 360, and Informatica adoption, and modest acceleration across Salesforce's much larger application business. The valuation remains attractive despite the recent recovery, with CRM trading at a 0.97x forward non-GAAP PEG, roughly 19% below the sector median.
Salesforce NYSE: CRM said its artificial intelligence product adoption is expanding across its customer base, with management highlighting growing demand for agentic workflows, consumption-based offerings and industry-specific AI applications during its Q2 fiscal 2027 investor webinar.
August was a good month for tech stocks, especially software companies that had slumped earlier in the year.
Salesforce just posted one of its best quarters ever, yet the stock sits down on the year and trades at a multiple reserved for slow-growth legacy vendors. Something in that gap has Wall Street scrambling to recalculate.
After a gloomy first half to the year, shares of Salesforce Inc. NYSE: CRM have been enjoying quite the recovery of late. Since June, the stock has surged more than 70%, and last week's earnings poured fresh fuel on the fire.
Salesforce's Q2 beat, Anthropic gain and AI momentum send shares soaring, while CRM-heavy ETFs offer diversified exposure with less single-stock risk.